+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Umbilical cord blood CD45(+)CD34(+) cells coexpression in preterm and full-term neonates: a pilot study



Umbilical cord blood CD45(+)CD34(+) cells coexpression in preterm and full-term neonates: a pilot study



Journal of Maternal-Fetal and Neonatal Medicine 24(2): 229-233



Human umbilical cord blood (hUCB) is rich in stem cells. The CD45(+)/CD34(+) coexpression in hUCB is a marker of hemopoietic progenitor cells. The objective of this study is to compare the coexpression of hUCB CD45(+)/CD34(+) cells in preterm (PT) and full-term (FT) neonates. We studied the coexpression of hUCB CD45(+)/CD34(+) cells in PT and FT neonates. The study included 25 PT (29-36 weeks gestation) and 25 FT (37-41) neonates delivered at Ain Shams University, Maternity Hospital. Absolute mononuclear layer cord blood CD45(+)/CD34(+) cell count were measured by flow cytometry. Morbidity was assessed for 12 of the studied 25 PT infants, using Morbidity Assessment Index for Newborns score. The absolute CD45(+)/CD34(+) count did not differ between PT and FT infants: Z =  -0.485, p = 0.63. There was no correlation between absolute cell count and GA (r = 0.013, p = 0.9) for all 50 neonates. Mode of delivery did not affect the absolute count in the PT infants: Z  =  -0.6, p  = 0.57. There was no correlation between the degree of morbidity and absolute cell count in PT neonates; r = 0.13, p = 0.69. The absolute cell count is not affected by gestational age and did not relate to morbidity scores in the studied PT infants. Further, wide-scale work will be needed to study CD45(+)/CD34(+) count in hUCB in sick PT neonates.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056745212

Download citation: RISBibTeXText

PMID: 20568956

DOI: 10.3109/14767058.2010.482606


Related references

Effect of cryopreservation on umbilical cord stem cells Percent CD34+ and viability in term and preterm cord blood after freezing. American Journal of Obstetrics & Gynecology 184(1): S92, 2001

Identification and quantification of CD34+ cord blood cells in preterm and term neonates by flow cytometry. British Journal of Haematology 102(1): 65, 1998

Cd34 positive hematopoietic stem cells and interleukin 6 in cord blood of term and preterm neonates. Onkologie 14(Suppl. 2): 109, 1991

Identification of CD34+ cord blood cells and their subpopulations in preterm and term neonates using three-color flow cytometry. Biology of the Neonate 66(5): 272-279, 1994

Cell cycle study of umbilical cord blood cells from premature and full term neonates. Blood 92(10 Suppl. 1 Part 1-2): 146B, 1998

Severe umbilical cord acidemia and neurological outcome in preterm and full-term neonates. Biology of the Neonate 88(1): 27-34, 2005

The synergistic effect of thrombopoietin in erythropoiesis with erythropoietin and/or IL-3 and myelopoiesis with G-CSF or IL-3 from umbilical cord blood cells of full-term neonates. Pediatric Hematology and Oncology 18(6): 383-391, 2001

CD45 tyrosine phosphatase inhibits erythroid differentiation of umbilical cord blood CD34+ cells. Experimental Hematology (Charlottesville) 30(6 Suppl. 1): 59, 2002

Effect of dimethyl sulfoxide on post-thaw viability assessment of CD45+ and CD34+ cells of umbilical cord blood and mobilized peripheral blood. Cryobiology 51(2): 165-175, 2005

CD45 tyrosine phosphatase inhibits erythroid differentiation of umbilical cord blood CD34+ cells associated with selective inactivation of Lyn. Blood 100(13): 4440-4445, 2002

Thawing methods do not affect cell viability of CD45+ and CD34+ cells, but long-term cryopreservation of umbilical cord blood units generally decreases cell viability. Transfusion and Apheresis Science 58(2): 196-200, 2019

Selectively amplified CD45+CD34+/-CD38-Lin- cells derived from frozen human umbilical cord blood are enriched in hematopoietic precursor cells while purged of unwanted mature T cells. FASEB Journal 16(5): A1244, 2002

An enriched population of CD45, CD34 and CD117 stem cells in human umbilical cord blood for potential therapeutic regenerative strategies. Current Neurovascular Research 11(4): 312-320, 2014

Human Umbilical Cord Blood CD34-Positive Cells as Predictors of the Incidence and Short-Term Outcome of Neonatal Hypoxic-Ischemic Encephalopathy: A Pilot Study. Journal of Clinical Neurology 13(1): 84-90, 2017

Adherent cells generated during long-term culture of human umbilical cord blood CD34+ cells have characteristics of endothelial cells and beneficial effect on cord blood ex vivo expansion. Stem Cells 21(2): 228-235, 2003